These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35789194)

  • 1. Impact of liver fibrosis score on the incidence of stroke: A cohort study.
    Xiong S; Yin S; Deng W; Zhao Y; Li W; Wang P; Li Z; Yang H; Zhou Y; Yu S; Guo X; Sun Y
    Liver Int; 2022 Oct; 42(10):2175-2185. PubMed ID: 35789194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population.
    Xiong S; Yin S; Deng W; Zhao Y; Li W; Wang P; Li Z; Yang H; Zhou Y; Yu S; Guo X; Sun Y
    J Hypertens; 2023 May; 41(5):741-750. PubMed ID: 36883472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between liver fibrosis scores and chronic kidney disease.
    Xiong S; Wang P; Yin S; Deng W; Zhao Y; Li W; Li Z; Zhou Y; Yu S; Yang H; Guo X; Sun Y
    Front Med (Lausanne); 2023; 10():1046825. PubMed ID: 36793875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction.
    Cao Y; Guo S; Dong Y; Liu C; Zhu W
    ESC Heart Fail; 2023 Jun; 10(3):1771-1780. PubMed ID: 36864701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of liver fibrosis score on prognosis in patients with previous myocardial infarction: A prospective cohort study.
    Cao YX; Zhang M; Zhang HW; Jin JL; Liu HH; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Dong Q; Sun J; Li JJ
    Liver Int; 2021 Jun; 41(6):1294-1304. PubMed ID: 33389804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention.
    Liu HH; Cao YX; Jin JL; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao RL; Li JJ
    J Am Heart Assoc; 2021 Feb; 10(3):e018869. PubMed ID: 33506689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Invasive Liver Fibrosis Scores Are Associated With Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.
    He HM; He C; You ZB; Zhang SC; Lin XQ; Luo MQ; Lin MQ; Zhang LW; Lin KY; Guo YS
    Angiology; 2023 Apr; 74(4):333-343. PubMed ID: 35642134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
    Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
    Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack.
    Baik M; Nam HS; Heo JH; Park HJ; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Lee HS; Kim SU; Kim YD
    Cerebrovasc Dis; 2020; 49(5):474-480. PubMed ID: 32980849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of the Age, Creatinine, and Ejection Fraction (ACEF) Score in Cardiovascular Disease among Middle-Aged Population.
    Xiong S; Yin S; Deng W; Zhao Y; Li W; Wang P; Li Z; Yang H; Zhou Y; Yu S; Guo X; Sun Y
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Cui CJ; Liu G; Sun J; Dong Q; Li JJ
    Hepatol Int; 2021 Apr; 15(2):413-423. PubMed ID: 33740211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease.
    Wu YL; Kumar R; Wang MF; Singh M; Huang JF; Zhu YY; Lin S
    World J Gastroenterol; 2021 Sep; 27(34):5753-5763. PubMed ID: 34629799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
    Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
    Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between indirect fibrosis and steatosis indices and their predictors in subjects with overweight/obesity.
    Melania G; Luisella V; Salvina DP; Francesca G; Amedea Silvia T; Fabrizia B; Maristella M; Filomena N; Kyriazoula C; Vassalle C
    Eat Weight Disord; 2022 Oct; 27(7):2617-2627. PubMed ID: 35527326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score.
    Klisic A; Abenavoli L; Fagoonee S; Kavaric N; Kocic G; Ninić A
    Minerva Med; 2019 Jun; 110(3):191-198. PubMed ID: 30784251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated red cell distribution width is associated with advanced fibrosis in NAFLD.
    Kim HM; Kim BS; Cho YK; Kim BI; Sohn CI; Jeon WK; Kim HJ; Park DI; Park JH; Joo KJ; Kim CJ; Kim YS; Heo WJ; Choi WS
    Clin Mol Hepatol; 2013 Sep; 19(3):258-65. PubMed ID: 24133663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
    Önnerhag K; Hartman H; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.
    Younes R; Caviglia GP; Govaere O; Rosso C; Armandi A; Sanavia T; Pennisi G; Liguori A; Francione P; Gallego-Durán R; Ampuero J; Garcia Blanco MJ; Aller R; Tiniakos D; Burt A; David E; Vecchio FM; Maggioni M; Cabibi D; Pareja MJ; Zaki MYW; Grieco A; Fracanzani AL; Valenti L; Miele L; Fariselli P; Petta S; Romero-Gomez M; Anstee QM; Bugianesi E
    J Hepatol; 2021 Oct; 75(4):786-794. PubMed ID: 34090928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.
    Cai X; Gao J; Hu J; Wen W; Zhu Q; Wang M; Liu S; Hong J; Wu T; Yang S; Tuerxun G; Li N
    Dis Markers; 2022; 2022():4930355. PubMed ID: 35251371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.